Azithromycin and Clarithromycin Inhibit Lipopolysaccharide-Induced Murine Pulmonary Neutrophilia Mainly through Effects on Macrophage-Derived Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-1β-Reference-Cited by-同舟云学术

Azithromycin and Clarithromycin Inhibit Lipopolysaccharide-Induced Murine Pulmonary Neutrophilia Mainly through Effects on Macrophage-Derived Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-1β

Published:2009-07-24 Issue:1 Volume:331 Page:104-113
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Bosnar Martina,Bošnjak Berislav,Čužić Snježana,Hrvačić Boška,Marjanović Nikola,Glojnarić Ines,Čulić Ognjen,Parnham Michael J.,Haber Vesna Eraković

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference30 articles.

1. New molecular targets for the treatment of neutrophilic diseases

2. Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4

3. Effects of azithromycin on ozone-induced airway neutrophilia and cytokine release

4. Long-term macrolide therapy in chronic inflammatory airway diseases

5. Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Of rodents, research and relationships: a pharmacological odyssey;Inflammopharmacology;2024-06-15

2. Enhanced infectivity of bovine viral diarrhoea virus (BVDV) in arginase-producing bovine monocyte-derived macrophages;Virulence;2023-11-15

3. The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice;Frontiers in Cellular and Infection Microbiology;2023-10-03

4. Pulmonary alveolar proteinosis postlung transplantation: A causation conundrum;JHLT Open;2023-10

5. Administration of macrolide antibiotics increases cardiovascular risk;Frontiers in Cardiovascular Medicine;2023-02-23